Applied Genetic


Applied Genetic Price Target Raised To $36 At Wedbush; Sees 16% Upside

In a research note issued earlier today, Wedbush analyst David Nierengarten maintained an Outperform and boosted his price target on Applied Genetic Technologies (AGTC) to $36.00 (from $24) …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts